Nutraceutical Joint Supplement

Verify with FDA CVM →

62 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
62
Total Reports
4
Deaths Reported
650.0%
Death Rate

Active Ingredients

Nutraceutical Joint Supplement

Administration Routes

UnknownOralOther

Species Affected

Dog 54
Cat 8

Most Affected Breeds

Retriever - Labrador 18
Domestic Shorthair 5
Collie - Border 3
Spitz - German Pomeranian 3
Crossbred Canine/dog 3
Dog (unknown) 3
Retriever - Golden 2
Spaniel - Cocker English 2
Pointing Dog - German Short-haired 2
Spaniel - King Charles Cavalier 2

Most Reported Reactions

Diarrhoea 13
Vomiting 9
Anorexia 6
Abnormal radiograph finding 6
Lack of efficacy - NOS 6
Decreased appetite 5
Not eating 5
Lack of efficacy (endoparasite) - roundworm NOS 5
Nausea 4
Anaemia NOS 4
Emesis (multiple) 4
Lethargy (see also Central nervous system depression in Neurological) 4

Outcome Breakdown

Outcome Unknown
25 (40.3%)
Ongoing
23 (37.1%)
Recovered/Normal
10 (16.1%)
Died
2 (3.2%)
Euthanized
2 (3.2%)

Data Summary

Metric Value
Total adverse event reports 62
Reports involving death 4
Case-fatality rate (reported events) 650.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Nutraceutical Joint Supplement Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 62 adverse event reports referencing Nutraceutical Joint Supplement, including 4 reports in which the animal died — a 650.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Nutraceutical Joint Supplement. Reported administration routes include Unknown, Oral, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Nutraceutical Joint Supplement reports are Dog (54 reports), Cat (8 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (18), Domestic Shorthair (5), Collie - Border (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Nutraceutical Joint Supplement are Diarrhoea (13), Vomiting (9), Anorexia (6), Abnormal radiograph finding (6). Of the 62 reports with a coded outcome, Outcome Unknown is the leading category at 40.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Nutraceutical Joint Supplement.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial